This is risky business. Only invest what you can afford to lose.
Followers | 0 |
Posts | 1,505 |
Boards Moderated | 0 |
Alias Born | 02/27/2012 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
6xs avg volume
May it BE indeed! LOTs to be excited about here!
We'll clean them out.
1,000 shares traded at Ask
~$$VYCO big VOL: 760K traded,6x's avg, Look for strong open after Holiday. Nice steady gains
~$$VYCO big VOL: 760K traded,6x's avg, Market liked the news. Rising tide of organic investor awarness. We will see strong busy on Thursday
~$$VYCO big VOL: 760K traded,6x's avg, Look for strong open on Thursday, Followed by even bigger Friday, look at historical trade, its the pattern lately. The DD here runs very deep
~$$VYCO big VOL: 760K traded,6x's avg, Look for strong open on Thursday, Followed by even bigger Friday, look at historical trade, its the pattern lately
~$$VYCO big VOL: 760K traded,6x's avg, Look for strong open on Thursday
~$$VYCO big VOL: 760K traded,6x's avg, Don't miss the next big play
$$VYCO awareness is growing. 740K shares traded, .021, 6x's average volume. DD is strong with this one:
http://a.eqcdn.com/harbingerresearch/media/b767cf61ff1d00bcf70bf414fab946a5.pdf
Listening right now. Cancelling 93,000 in convertible debt and 100mm warrant cancellation will make that balance sheet much stronger. Sounds better and better. Credit line is big too.
This is HUGE imo:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76441143
Definitely taking a closer look here
Yes. 652mm of 900mm shares (approx) of the outstanding are held by insiders and are locked down in a 10B5-1 plan with the broker of record registered with the SEC and contractually can't be sold for less than 8 cents. And half of that is in the form of preferred.
Many of the insiders have been with VYCO for quite awhile. The big risk for them was 9 years ago *before* they had FDA approval. Now with FDA approval on two of their flagship technologies, rising revenues, 3000 procedures performed in hundreds of hospitals, a strong patent portfolio, resounding endorsement from the scientific community (Harvard Medical School and Aberdeen University Profs on the board), lives saved by their technology and international markets rapidly expanding in a $10B industry (the DD goes on and on) : the risk is essentially out of the deal for those insiders and I doubt they will convert at a measly 8 cents after hanging in there for 9 years.
A 4 to 5 x's increase seems in easy reach. 10x's to 15x's not at all out of the range of possibility, imo.
Have a great 4th everybody!
Nice to see you here lucasharp2008! Thanks for posting. I'm definitely long here. The DD is solid and the financials tell a rising story. If you haven't checked out this analysis, I think you'll find it illuminating
http://a.eqcdn.com/harbingerresearch/media/b767cf61ff1d00bcf70bf414fab946a5.pdf
Looks a little malicious. Interesting to see where we open on Thursday.
The awarness here is just gaining steam.
NITE can't hold it back long. I'm banking on green again by the end of the week.
Somebody needs to take the idiot stick and beat the snot out of the moron on NITE
Yes, this is only the foothills in the climb to the peak. Joe Public still has a low awareness on this. We are seeing the smart money get in.
Beginning of a beautiful story, imo ;-D
Exactly right. You can't fake one like this. Deep pocket investors don't line up like this without strong fundamentals.
Huge. I think those private Conf Calls has alot to do with those rapid fans as well. \\
The story here is just irresistible
To me the best sign of things to come is that this is still quite the undiscovered jewel. Just look at the board marks. Not the average IHUB pump and dump here.
Investors have been buying and holding on the strength of the organic awareness alone.
Anyone who spends an hour with the DD here gets a buying gleam in their eye.
534K traded, almost 4times the average volume. 75% of that is buys
VYCO has been a rising story for some time know. Expecting to see those .022's cleared out soon
"...Richard Denness as the new CEO of Vycor...has the operations, strategic, and management leadership experience required to run a fast moving healthcare company such as Vycor. We believe he is ideally equipped to take Vycor forward into the next exciting phase of its development. At the same time, Vycor owes a huge debt of gratitude to Ken, who has led the company from inception and we wish him all the best with his future plans."
Great to see Vycor proactively laying the strategy for future growth
Vycor Medical, Inc. Announces Leadership Change, Appoints New Chief Executive Officer
http://finance.yahoo.com/news/vycor-medical-inc-announces-leadership-180000201.html
BOCA RATON, FL--(Marketwire -07/02/12)- Vycor Medical, Inc. ("Vycor") (VYCO) today announces that Richard P. Denness will be joining Vycor as its new Chief Executive Officer, replacing Ken Coviello. During this transition period, Ken will retain a role with the company on a consultancy basis. Since the acquisitions of NovaVision, Inc. and Sight Science Limited, Vycor has become an international group of greater complexity with several businesses. Richard Denness is a healthcare executive with global experience who has held senior management positions at UCB, Inc., Schwarz Pharma US, Schering-Plough and IVAX Corporation.
Kenneth T. Coviello, the current Chief Executive Officer of Vycor, has played a crucial role in the development of Vycor and its VBAS product line, which has been achieving excellent growth and progress in US and international markets. Ken had indicated to the Board a desire to pursue personal interests and pass the role on to a new executive to take Vycor forward to the next level, once an appropriate successor could be found.
Adrian Liddell, Chairman of Vycor, stated: "We are delighted to welcome Richard as the new CEO of Vycor; Richard has the operations, strategic, and management leadership experience required to run a fast moving healthcare company such as Vycor. We believe he is ideally equipped to take Vycor forward into the next exciting phase of its development. At the same time, Vycor owes a huge debt of gratitude to Ken, who has led the company from inception and we wish him all the best with his future plans."
About Vycor Medical, Inc.
With corporate headquarters in Boca Raton, FL, Vycor Medical, Inc. (VYCO) is a medical device company committed to making neurological brain, spinal and other surgical procedures safer and more effective. The company's flagship, Patent Pending ViewSiteâ„¢ Surgical Access Systems represent an exciting new minimally invasive access and retraction system that holds the potential for speedier, safer and more economical brain, spinal and other surgeries and a quicker patient discharge. Vycor's innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery, and add tangible value to the professional medical community. Vycor is ISO 13485:2003 compliant, has FDA 510(K) clearance for brain and spine surgeries, and CE Marking and HPB licensing in Canada.
Vycor Medical's subsidiary, NovaVision, Inc., researches, develops and provides science-driven vision-based neurostimulation therapy and other medical technologies that help to improve sight in patients with neurological vision impairments. The company's proprietary, Visual Restoration Therapy (VRT) platform is clinically supported to improve lost vision resulting from stroke, traumatic brain injury ("TBI"), or other acquired brain injury, and has been 510(K) cleared to be marketed in the US by the FDA. VRT can be prescribed by any ophthalmologist, optometrist, neurologist or physiatrist. NovaVision, through its subsidiary Sight Science, also provides Neuro-Eye Therapy (NeET), aimed at increasing visual sensitivity deep within the field defect. NovaVision also provides a fully portable and ADA-compliant Head Mounted Perimeter (HMPâ„¢) which aids in the detection and measurement of visual field deficits.
For the latest information on the company, including media and other coverage, and to learn more, please go online at www.vycormedical.com or www.novavision.com.
Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast," "anticipate," "estimate," "project," "intend," "expect," "should," "believe," and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Vycor Medical's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Vycor Medical's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Vycor Medical herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Vycor Medical disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
Contact:
Lenny Sorin
Vycor Medical, Inc.
561-558-2000
Email Contact
Good Morning VYCO land What does today hold? I'm expecting to see more accumulation
This low level loading is the precursor to a steep rise imo
Another solid day of accumulation with mostly buys. Nice to have a dip or two here and there to continue loading at discount. BIG things right around the bend here.
LOL, it's hard not to be excited about what's going on with VYCO. I chatted with
a few more deep pocket investors over the weekend who have been combing through the DD here.
The pattern is the same, anyone who spends an hour with the facts here starts salivating about the upside
Good Morning VYCO fans! Let's make some hay indeed ;-D
That last call really galvanized the little group of investors on the call. Can you imagine what might happen when the word really starts travelling?
VYCO grassroots exposure is gaining steam. Hidden gems like this usually start with a trickle, then a drizzle, then a steady pour.But when the malthus curve hits the incline you won't want to blink then
Slow and steady wins this race most definitely.
~VYCO .0205 x .022--goodbye .02's, close .025?, volume!
~VYCO .0205 x .022-- last chance, close .025?, volume spike